Search Within

David Hyman

  1. "Center for Molecular Imaging and Biotechnology (CMIB)"
Formats
  1. Journal Article (63)
  2. Meeting Abstract (54)
  3. Research Letter (2)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (119)
  2. Department of Medicine (119)
  3. Early Drug Development Service (119)
  4. GSK Faculty (119)
  5. Solid Tumor Oncology Division (119)
  6. Human Oncology and Pathogenesis Program (117)

More Groups

People
  1. Michael Berger (105)
  2. David Solit (85)
  3. Ahmet Zehir (62)
  4. Marc Ladanyi (60)
  5. Maria Arcila (42)
  6. Jose Baselga (36)

More People

Years
  1. 2022 (1)
  2. 2021 (3)
  3. 2020 (10)
  4. 2019 (25)
  5. 2018 (24)
  6. 2017 (23)

More Years

Publications
  1. Journal of Clinical Oncology (32)
  2. Cancer Research (13)
  3. Cancer Discovery (11)
  4. Clinical Cancer Research (8)
  5. JCO Precision Oncology (6)
  6. Annals of Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (38)
  2. American Association for Cancer Research (32)
  3. Nature Publishing Group (12)
  4. American Medical Association (5)
  5. American Society of Hematology (5)
  6. Oxford University Press (5)

More Publishers

Results (119)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mechanisms of acquired resistance to BRAF V600E inhibition in colon cancers converge on RAF dimerization and are sensitive to its inhibition
    Journal Article

    Yaeger, R.; Yao, Z.; Hyman, D. M.; Hechtman, J. F.; Vakiani, E.; Zhao, H.; Su, W.; Wang, L.; Joelson, A.; Cercek, A.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • (89)Zr-trastuzumab PET/CT for detection of human epidermal growth factor receptor 2-positive metastases in patients with human epidermal growth factor receptor 2-negative primary breast cancer
    Journal Article

    Ulaner, G. A.; Hyman, D. M.; Lyashchenko, S. K.; Lewis, J. S.; Carrasquillo, J. A.
    Clinical Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Real-time genomic profiling of pancreatic ductal adenocarcinoma: Potential actionability and correlation with clinical phenotype
    Journal Article

    Lowery, M. A.; Jordan, E. J.; Basturk, O.; Ptashkin, R. N.; Zehir, A.; Berger, M. F.; Leach, T.; Herbst, B.; Askan, G.; Maynard, H.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Oncologist use and perception of large panel next-generation tumor sequencing
    Journal Article

    Schram, A. M.; Reales, D.; Galle, J.; Cambria, R.; Durany, R.; Feldman, D.; Sherman, E.; Rosenberg, J.; D'Andrea, G.; Baxi, S.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes
    Journal Article

    Coombs, C. C.; Zehir, A.; Devlin, S. M.; Kishtagari, A.; Syed, A.; Jonsson, P.; Hyman, D. M.; Solit, D. B.; Robson, M. E.; Baselga, J.; more...
    Cell Stem Cell (2017)

    Fulltext@MSK | Save
  • Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Journal Article

    Mandelker, D.; Zhang, L.; Kemel, Y.; Stadler, Z. K.; Joseph, V.; Zehir, A.; Pradhan, N.; Arnold, A.; Walsh, M. F.; Li, Y.; more...
    JAMA - Journal of the American Medical Association (2017)

    Fulltext@MSK | Save
  • A next-generation TRK kinase inhibitor overcomes acquired resistance to prior TRK kinase inhibition in patients with TRK fusion-positive solid tumors
    Journal Article

    Drilon, A.; Nagasubramanian, R.; Blake, J. F.; Ku, N.; Tuch, B. B.; Ebata, K.; Smith, S.; Lauriault, V.; Kolakowski, G. R.; Brandhuber, B. J.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • AACR Project GENIE: Powering precision medicine through an international consortium
    Journal Article

    The AACR Project GENIE Consortium
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma
    Journal Article

    Teo, M. Y.; Bambury, R. M.; Zabor, E. C.; Jordan, E.; Al-Ahmadie, H.; Boyd, M. E.; Bouvier, N.; Mullane, S. A.; Cha, E. K.; Roper, N.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • AKT inhibition in solid tumors with AKT1 mutations
    Journal Article

    Hyman, D. M.; Smyth, L. M.; Donoghue, M. T. A.; Westin, S. N.; Bedard, P. L.; Dean, E. J.; Bando, H.; El-Khoueiry, A. B.; PeĢrez-Fidalgo, J. A.; Mita, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save